Complete Filing Data
Structure Therapeutics Inc. reported Stockholders Equity of $1.52 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Structure Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$141.2M | -$122.5M | -$89.6M | -$51.3M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $140.0K | $393.0K | $631.0K | -$110.0K |
| Research And Development Expense | $225.3M | $108.8M | $70.1M | $36.2M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $140.0K | $393.0K | $631.0K | -$110.0K |
| Operating Income Loss | -$176.6M | -$158.2M | -$102.8M | -$52.6M |
| Operating Expenses | $176.6M | $158.2M | $102.8M | $52.6M |
| Income Tax Expense Benefit | $515.0K | $310.0K | $236.0K | $17.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$140.7M | -$122.2M | -$89.4M | -$51.3M |
| General And Administrative Expense | $61.6M | $49.4M | $32.7M | $16.4M |
| Comprehensive Income Net Of Tax | -$141.1M | -$122.1M | -$89.0M | -$51.4M |
| Net Income Loss Available To Common Stockholders Basic | -$89.6M | -$52.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$65.7M | -$61.7M | -$46.8M | -$34.0M | -$26.0M | -$26.0M | -$23.9M | -$23.3M | -$18.0M | -$12.4M | -$13.9M | -$13.1M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $463.0K | -$453.0K | -$99.0K | $3.3M | -$397.0K | -$611.0K | $80.0K | -$537.0K | $257.0K | -$50.0K | -$50.0K | -$35.0K |
| Research And Development Expense | $59.0M | $54.7M | $42.9M | $32.6M | $22.1M | $20.7M | $17.5M | $19.4M | $13.1M | $9.2M | $10.2M | $8.5M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $463.0K | -$453.0K | -$99.0K | $3.3M | -$397.0K | -$611.0K | $80.0K | -$537.0K | $257.0K | -$50.0K | -$50.0K | -$35.0K |
| Operating Income Loss | -$73.8M | -$70.5M | -$56.3M | -$45.8M | -$33.3M | -$32.0M | -$26.1M | -$26.0M | -$19.6M | -$12.7M | -$14.0M | -$13.0M |
| Operating Expenses | $73.8M | $70.5M | $56.3M | $45.8M | $33.3M | $32.0M | $26.1M | $26.0M | $19.6M | $12.7M | $14.0M | $13.0M |
| Income Tax Expense Benefit | $108.0K | $139.0K | $98.0K | $92.0K | $53.0K | $29.0K | $405.0K | $118.0K | $25.0K | $73.0K | $64.0K | $60.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$65.6M | -$61.5M | -$46.7M | -$33.9M | -$26.0M | -$26.0M | -$23.5M | -$23.2M | -$18.0M | -$12.3M | -$13.9M | -$13.0M |
| General And Administrative Expense | $14.8M | $15.7M | $13.4M | $13.2M | $11.3M | $11.3M | $8.6M | $6.6M | $6.5M | $3.5M | $3.8M | $4.5M |
| Comprehensive Income Net Of Tax | -$65.2M | -$62.1M | -$46.9M | -$30.7M | -$26.4M | -$26.6M | -$23.8M | -$23.8M | -$17.7M | -$12.5M | -$14.0M | -$13.1M |
| Net Income Loss Available To Common Stockholders Basic | -$34.0M | -$26.0M | -$26.0M | -$23.9M | -$23.3M | -$18.0M | -$12.4M | -$15.5M | -$13.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $1.52B | $864.8M | $453.0M | -$115.1M | -$64.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $799.6M | $169.5M | $129.8M | $26.1M | $105.3M |
| Non Cash Lease Expense | $2.2M | $1.6M | $634.0K | $347.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $630.1M | $39.7M | $103.7M | -$79.2M | |
| Short Term Investments | $646.6M | $714.0M | $337.5M | $64.8M | |
| Retained Earnings Accumulated Deficit | -$470.3M | -$329.1M | -$206.6M | -$117.0M | |
| Property Plant And Equipment Net | $6.7M | $3.5M | $3.2M | $1.0M | |
| Prepaid Expense And Other Assets Current | $24.1M | $7.7M | $6.3M | $2.2M | |
| Other Assets Noncurrent | $717.0K | $5.1M | $45.0K | $3.5M | |
| Operating Lease Right Of Use Asset | $6.2M | $3.5M | $5.1M | $262.0K | |
| Operating Lease Liability Current | $2.9M | $1.7M | $1.4M | $260.0K | |
| Liabilities Current | $63.3M | $36.0M | $24.7M | $13.0M | |
| Liabilities And Stockholders Equity | $1.58B | $903.3M | $482.0M | $97.8M | |
| Liabilities | $67.5M | $38.5M | $29.1M | $13.0M | |
| Cash And Cash Equivalents At Carrying Value | $799.6M | $169.5M | $129.8M | $26.1M | |
| Assets Current | $1.57B | $891.2M | $473.6M | $93.1M | |
| Assets | $1.58B | $903.3M | $482.0M | $97.8M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.1M | $914.0K | $521.0K | -$110.0K | |
| Accrued Expenses And Other Liabilities Current | $46.5M | $26.3M | $18.6M | $6.7M | |
| Accounts Payable Current | $13.9M | $8.0M | $4.7M | $6.0M | |
| Common Stock Value | $21.0K | $17.0K | $14.0K | $1.0K | |
| Other Liabilities Noncurrent | $647.0K | $302.0K | $298.0K | ||
| Operating Lease Liability Noncurrent | $3.6M | $2.2M | $4.0M | ||
| Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities | $442.0K | $100.0K | $53.0K | ||
| Temporary Equity Carrying Amount Attributable To Parent | $200.0M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $4.9M | $5.5M | |||
| Deferred Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities | $53.0K | $854.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $770.0M | $772.1M | $824.6M | $896.8M | $921.0M | $429.8M | $193.0M | $214.4M | $236.4M | -$103.9M | -$92.1M | -$77.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $102.9M | $147.0M | $152.1M | $172.1M | $381.6M | $97.8M | $50.6M | $40.6M | $126.5M | $28.1M | $55.5M | $50.6M | |
| Non Cash Lease Expense | $412.0K | $438.0K | $84.0K | $82.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$17.4M | -$32.0M | $100.4M | -$54.7M | |||||||||
| Short Term Investments | $696.1M | $639.5M | $684.8M | $743.2M | $545.5M | $338.6M | $154.8M | $184.0M | $114.4M | ||||
| Retained Earnings Accumulated Deficit | -$503.3M | -$437.6M | -$375.9M | -$292.6M | -$258.6M | -$232.6M | -$182.1M | -$158.2M | -$134.9M | ||||
| Property Plant And Equipment Net | $4.7M | $3.5M | $3.5M | $3.7M | $3.3M | $3.1M | $2.4M | $1.1M | $961.0K | ||||
| Prepaid Expense And Other Assets Current | $15.0M | $12.8M | $12.7M | $8.4M | $10.5M | $12.9M | $4.5M | $3.6M | $5.3M | ||||
| Other Assets Noncurrent | $6.6M | $6.2M | $6.1M | $1.8M | $1.8M | $47.0K | $350.0K | $38.0K | $59.0K | ||||
| Operating Lease Right Of Use Asset | $6.9M | $7.5M | $7.3M | $4.0M | $4.3M | $4.7M | $3.7M | $90.0K | $178.0K | ||||
| Operating Lease Liability Current | $2.8M | $2.7M | $2.5M | $1.7M | $1.6M | $1.6M | $817.0K | $73.0K | $168.0K | ||||
| Liabilities Current | $57.5M | $39.0M | $36.5M | $33.4M | $22.7M | $23.6M | $20.1M | $15.0M | $11.0M | ||||
| Liabilities And Stockholders Equity | $832.2M | $816.4M | $866.5M | $933.2M | $947.0M | $457.2M | $216.4M | $229.4M | $247.4M | ||||
| Liabilities | $62.1M | $44.4M | $41.9M | $36.4M | $26.0M | $27.4M | $23.4M | $15.0M | $11.0M | ||||
| Cash And Cash Equivalents At Carrying Value | $102.9M | $147.0M | $152.1M | $172.1M | $381.6M | $97.8M | $50.6M | $40.6M | $126.5M | ||||
| Assets Current | $814.0M | $799.3M | $849.6M | $923.7M | $937.6M | $449.4M | $210.0M | $228.2M | $246.2M | ||||
| Assets | $832.2M | $816.4M | $866.5M | $933.2M | $947.0M | $457.2M | $216.4M | $229.4M | $247.4M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $825.0K | $362.0K | $815.0K | $2.8M | -$487.0K | -$90.0K | -$310.0K | -$390.0K | $147.0K | ||||
| Accrued Expenses And Other Liabilities Current | $36.9M | $27.4M | $25.3M | $23.3M | $18.8M | $15.4M | $16.0M | $9.2M | $5.9M | ||||
| Accounts Payable Current | $17.8M | $9.0M | $8.7M | $8.4M | $2.2M | $6.5M | $3.3M | $5.7M | $4.9M | ||||
| Common Stock Value | $18.0K | $17.0K | $17.0K | $17.0K | $17.0K | $14.0K | $11.0K | ||||||
| Other Liabilities Noncurrent | $325.0K | $317.0K | $308.0K | $309.0K | $293.0K | $296.0K | $281.0K | ||||||
| Operating Lease Liability Noncurrent | $4.3M | $5.0M | $5.1M | $2.7M | $3.0M | $3.5M | $3.0M | ||||||
| Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities | $100.0K | $416.0K | |||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | |||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $4.2M | ||||||||||||
| Deferred Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities | $416.0K | $396.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Share Based Compensation | $29.0M | $18.8M | $8.2M | $2.5M |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $630.5M | $344.9M | $151.2M | $61.5M |
| Payments To Acquire Short Term Investments | $547.4M | $702.5M | $417.4M | $123.5M |
| Net Cash Provided By Used In Operating Activities | -$222.2M | -$116.6M | -$79.5M | -$46.1M |
| Net Cash Provided By Used In Investing Activities | $89.8M | -$358.9M | -$268.3M | -$62.1M |
| Net Cash Provided By Used In Financing Activities | $762.5M | $515.3M | $451.5M | $29.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $16.4M | $1.4M | $4.0M | $305.0K |
| Increase Decrease In Operating Lease Liability | -$2.3M | -$1.6M | -$315.0K | -$361.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $21.5M | $7.7M | $12.2M | $1.5M |
| Increase Decrease In Accounts Payable | $4.8M | $3.3M | -$860.0K | $2.2M |
| Proceeds From Stock Options Exercised | $4.5M | $1.9M | $800.0K | $33.0K |
| Payments To Acquire Property Plant And Equipment | $3.6M | $1.3M | $2.2M | $155.0K |
| Payments Of Debt Issuance Costs | $2.0M | $1.8M | $21.6M | |
| Increase Decrease In Other Noncurrent Assets | -$4.4M | $5.1M | -$15.0K | $60.0K |
| Proceeds From Issuance Initial Public Offering | $172.3M | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 921.0K | 632.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Share Based Compensation | $5.9M | $2.7M | $2.5M | $620.0K |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $150.5M | $33.5M | $141.1M | $2.0M |
| Payments To Acquire Short Term Investments | $116.1M | $31.9M | $190.1M | $41.7M |
| Net Cash Provided By Used In Operating Activities | -$52.2M | -$34.1M | -$20.3M | -$13.5M |
| Net Cash Provided By Used In Investing Activities | $34.0M | $1.4M | -$49.0M | -$39.7M |
| Net Cash Provided By Used In Financing Activities | $809.0K | $702.0K | $169.7M | -$1.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.0M | $6.6M | $3.0M | $97.0K |
| Increase Decrease In Operating Lease Liability | -$459.0K | -$328.0K | -$92.0K | -$74.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$993.0K | -$3.0M | -$555.0K | $536.0K |
| Increase Decrease In Accounts Payable | $686.0K | $1.8M | -$923.0K | -$1.6M |
| Proceeds From Stock Options Exercised | $965.0K | $755.0K | $31.0K | |
| Payments To Acquire Property Plant And Equipment | $314.0K | $162.0K | $65.0K | |
| Payments Of Debt Issuance Costs | $53.0K | $2.6M | $1.4M | |
| Increase Decrease In Other Noncurrent Assets | $990.0K | $2.0K | $59.0K | |
| Proceeds From Issuance Initial Public Offering | $172.3M | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 177.6M | 157.9M | 110.2M | 9.6M |
| Earnings Per Share Basic | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
| Weighted Average Number Of Diluted Shares Outstanding | 177.6M | 157.9M | 110.2M | 9.6M |
| Earnings Per Share Diluted | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 212.5M | 171.9M | 139.2M | 10.5M |
| Common Stock Shares Issued | 212.5M | 171.9M | 139.2M | 10.5M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 433.0M |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | ||
| Temporary Equity Shares Issued | 0.00 | 0.00 | 67.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 175.5M | 172.6M | 172.1M | 171.6M | 148.2M | 139.7M | 114.9M | 114.8M | 71.7M | 9.8M | 9.4M | 9.1M | |
| Earnings Per Share Basic | $-0.37 | $-0.36 | $-0.27 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.27 | $-1.64 | $-1.44 | |
| Weighted Average Number Of Diluted Shares Outstanding | 175.5M | 172.1M | 171.6M | 148.2M | 139.7M | 114.9M | 114.8M | 71.7M | 9.8M | 9.4M | 9.1M | ||
| Earnings Per Share Diluted | $-0.37 | $-0.27 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.27 | $-1.64 | $-1.44 | ||
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 90.2M | 100.0M | 92.6M | 100.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 182.0M | 172.7M | 172.6M | 171.8M | 171.6M | 139.9M | 114.7M | ||||||
| Common Stock Shares Issued | 182.0M | 172.7M | 172.6M | 171.8M | 171.6M | 139.9M | 114.7M | ||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||||||
| Temporary Equity Shares Outstanding | 0.00 | 67.0M | |||||||||||
| Temporary Equity Shares Issued |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $29.0M | $18.8M | $8.2M | $2.5M |
| Stock Issued During Period Value Stock Options Exercised | $4.5M | $1.9M | $800.0K | $33.0K |
| Interest And Other Income Expense Net | $35.9M | $36.0M | $13.4M | $1.3M |
| Investment Income Net Amortization Of Discount And Premium | $15.6M | $18.5M | $6.0M | $905.0K |
| Depreciation | $1.3M | $992.0K | $295.0K | $277.0K |
| Additional Paid In Capital | $1.99B | $1.19B | $659.0M | $1.9M |
| Stock Issued During Period Value Conversion Of Convertible Securities | $200.0M | |||
| Stock Issued During Period Shares Stock Options Exercised | 1.3M | 498.0K | ||
| Asset Retirement Obligation Accretion Expense | $345.0K | $4.0K | $21.0K | |
| Stock Issued During Period Value New Issues | $281.5M | |||
| Conversion Of Redeemable Convertible Preferred Shares Into Ordinary Shares Upon Initial Public Offering | 200.0M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $921.0K | $632.0K | ||
| Exchange Of Ordinary Shares To Non Voting Ordinary Shares | 1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.5M | $7.5M | $5.9M | $6.0M | $4.2M | $2.7M | $1.9M | $1.7M | $2.5M | $628.0K | $643.0K | $620.0K |
| Stock Issued During Period Value Stock Options Exercised | $377.0K | $43.0K | $965.0K | $397.0K | $478.0K | $755.0K | $473.0K | $179.0K | $31.0K | $29.0K | $4.0K | |
| Interest And Other Income Expense Net | $8.2M | $8.9M | $9.6M | $12.0M | $7.3M | $6.0M | $2.7M | $2.8M | $1.7M | $349.0K | $76.0K | -$69.0K |
| Investment Income Net Amortization Of Discount And Premium | $5.2M | $3.3M | $346.0K | $17.0K | ||||||||
| Depreciation | $274.0K | $222.0K | $70.0K | $70.0K | ||||||||
| Additional Paid In Capital | $1.27B | $1.21B | $1.20B | $1.19B | $1.18B | $662.5M | $375.3M | $373.0M | $371.1M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $200.0M | |||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 635.0K | 26.0K | ||||||||||
| Asset Retirement Obligation Accretion Expense | ||||||||||||
| Stock Issued During Period Value New Issues | $512.7M | $166.7M | ||||||||||
| Conversion Of Redeemable Convertible Preferred Shares Into Ordinary Shares Upon Initial Public Offering | 200.0M | |||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $474.0K | $241.0K | ||||||||||
| Exchange Of Ordinary Shares To Non Voting Ordinary Shares |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.